Literature DB >> 3192570

The predictability of acetabular development after closed reduction for congenital dislocation of the hip.

D I Brougham1, N S Broughton, W G Cole, M B Menelaus.   

Abstract

We have reviewed the serial radiographs of 63 hips in 53 children treated by closed reduction for congenital dislocation with a view to finding a radiological measurement which can predict subsequent acetabular development. All had been followed for more than seven years, and at latest review, 34 hips were dysplastic. Failure to obtain concentric reduction or its loss by migration of the femoral head within one year of reduction were the best predictors of persisting acetabular dysplasia and were best quantitated by the h/b ratio (Smith et al. 1968). The acetabular index at reduction or its decrease in the first year were not reliable predictors. Late treatment was less likely to lead to normal acetabular development, but avascular necrosis did not appear to have a significant influence. The average age at which the acetabulum stopped developing was five years, but ranged from 17 months to eight years. The failure of a dysplastic acetabulum to improve in each annual radiograph after closed reduction should lead to consideration of operation on the acetabulum.

Entities:  

Mesh:

Year:  1988        PMID: 3192570

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  14 in total

1.  Evaluation of Acetabular Development Following Open Reduction of Developmental Dysplasia of Hip in Children After Walking Age.

Authors:  Sandeep Patwardhan; Arkesh Madegowda; Parag Sancheti
Journal:  Indian J Orthop       Date:  2021-09-22       Impact factor: 1.033

2.  Retrospective analysis of the radiographic indicators for peri-acetabular osteotomy of developmental dysplasia in children.

Authors:  Yunfang Zhen; Chunhua Yin; Shiping Tan; Quanwen Yuan; Lunqing Zhu; Xiaodong Wang
Journal:  Int Orthop       Date:  2015-11-28       Impact factor: 3.075

3.  Osteonecrosis complicating developmental dysplasia of the hip compromises subsequent acetabular remodeling.

Authors:  Andreas Roposch; Deborah Ridout; Evangelia Protopapa; Nicholas Nicolaou; Yael Gelfer
Journal:  Clin Orthop Relat Res       Date:  2013-01-26       Impact factor: 4.176

4.  Natural history of type III growth disturbance after treatment of developmental dislocation of the hip.

Authors:  Claudio A Fernandez; Lori A Dolan; Stuart L Weinstein; Jose A Morcuende
Journal:  Iowa Orthop J       Date:  2008

Review 5.  [Indications and results of corrective pelvic osteotomies in developmental dysplasia of the hip].

Authors:  M Jäger; B Westhoff; C Zilkens; K Weimann-Stahlschmidt; R Krauspe
Journal:  Orthopade       Date:  2008-06       Impact factor: 1.087

6.  Treatment of developmental dysplasia of the hip (DDH) between the age of 18 and 24 months.

Authors:  Nabil Alassaf
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-12-21

7.  MR-based parameters as a supplement to radiographs in managing developmental hip dysplasia.

Authors:  Hui-Taek Kim; In-Bo Kim; Jong-Seo Lee
Journal:  Clin Orthop Surg       Date:  2011-08-19

8.  Outcome of surgical management of developmental dysplasia of hip in children between 18 and 24 months.

Authors:  Narasimhan Ramani; Mithun S Patil; Madhur Mahna
Journal:  Indian J Orthop       Date:  2014-09       Impact factor: 1.251

9.  Does Adductor Tenotomy Need During Closed Reduction Have a Prognostic Value in the Treatment of Developmental Dysplasia of the Hip Between 6 and 12 Months of Age? "Adductor Tenotomy in the Treatment of Developmental Dysplasia''.

Authors:  Hanifi Ucpunar; Muhammed Mert; Yalkin Camurcu; Hakan Sofu; Timur Yildirim; Avni Ilhan Bayhan
Journal:  Indian J Orthop       Date:  2020-03-09       Impact factor: 1.251

10.  Which Acetabular Landmarks are the Most Useful for Measuring the Acetabular Index and Center-edge Angle in Developmental Dysplasia of the Hip? A Comparison of Two Methods.

Authors:  Chang Ho Shin; Eunkyu Yang; Chaemoon Lim; Won Joon Yoo; In Ho Choi; Tae-Joon Cho
Journal:  Clin Orthop Relat Res       Date:  2020-09       Impact factor: 4.755

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.